Experiences of psilocybin treatment for clinical conditions: A qualitative meta‐synthesis
Marie Crowe, Jenni Manuel, Dave Carlyle, Cameron Lacey
International Journal of Mental Health Nursing February 13, 2023 DOI: 10.1111/inm.13127 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative meta-synthesis Peer reviewed |
|---|---|
| Population | People with cancer, depression, HIV, substance use disorder, smoking cessation, and trauma |
| Intervention | Psilocybin |
| Topics | Psilocybin |
| Keywords | Hallucinogen Psychotherapist Clinical psychology Mental health |
| Citations | 18 |
| Key findings | Across ten studies, people treated with psilocybin described their experiences through three common themes: acceptance, connection, and transformation, regardless of the health condition. |
Abstract
Abstract There is increasing clinical interest in the use of psilocybin. There is emerging evidence of the efficacy of psilocybin for the treatment of a range of clinical conditions. Mental health nurses have a unique set of skills for caring for people who are hallucinating. To expand these skills to meet the developing clinical interest in the therapeutic use of psilocybin, it is helpful to understand the experience from the perspective of the person being treated with psilocybin. A qualitative meta‐synthesis was conducted to examine how those with psilocybin described their experiences to identify whether its effects are similar across different health conditions. Ten studies were included in the review. The health conditions studied were cancer, depression, HIV, substance use disorder, smoking cessation and trauma. The synthesis of findings identified three themes that were common across the studies despite the health condition: acceptance, connection and transformation. The review provides helpful insights into how people experience psilocybin and its effects on their health condition.